01189
Gastroenterology Division | 醫師代碼:01189

AN-MING YANG

  • Education

    • PhD, Department of Biomedical Sciences and Engineering, National Central University, Taoyuan city, Taiwan
    • MS, Institute of Molecular Medicine, School of medicine, National Taiwan University, Taipei city, Taiwan
    • MD, China Medical University, Taichung city, Taiwan
  • Experience

    • Attending Physician, GI section, Department of Internal Medicine, En Chu Kong Hospital, Taiwan. 2006~now
    • Assistant professor, Yuan Pei University, Taiwan. 2017~2019
    • Visiting Scholar, Department of Medicine, School of Medicine, University of California, San Diego, USA. 2014~2016 (Mentor: Professor Bernd Schnabl)
  • Current position

  • Specialty

  • Learning / Qualification / Other

    • Regular member of America Association of Study of Liver Disease (AASLD)

    Google Scholar

    Publication (Peer-review paper)

    •  Intestinal fungi contribute to development of alcoholic liver disease. AM Yang, T Inamine, K Hochrath, P Chen, L Wang, C Llorente, S Bluemel, et al. The Journal of Clinical Investigation 127 (7)     3 2017
    • Genetic loss of immunoglobulin A does not influence development of alcoholic steatohepatitis in mice. T Inamine, AM Yang, L Wang, KC Lee, C Llorente, B Schnabl Alcoholism: Clinical and Experimental Research 40 (12), 2604-2613 2 2016
    • Methods to determine intestinal permeability and bacterial translocation during liver disease L Wang, C Llorente, P Hartmann, AM Yang, P Chen, B Schnabl Journal of immunological methods 421, 44-53 25 2015
    • Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients. AM Yang, LL Wen, CS Yang, SC Wang, CS Chen, MJ Bair The Kaohsiung journal of medical sciences 30 (6), 291-298 8 2014
    • PRKCSH genetic mutation was not found in taiwanese patients with polycystic liver disease AM Yang, SC Shih, CH Chu, TE Wang, WS Yang Digestive diseases and sciences 55 (3), 815-819 3 2010
    • Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients. CH Chu, AM Yang, JH Kao, CY Liu, WH Chang, WS Yang Journal of gastroenterology and hepatology 24 (9), 1559-1561 4 2009
    • Hepatocellular Carcinoma Presenting as Testicular Mass A Case Report. AM Yang, SC Shih, WS Chang, BF Chen, SC Lin J Int Med of Taiwan 16, 274-278 1 2005
    • Clinical analysis of multiple primary malignancies in the digestive system: a hospital-based study. HY Cheng, CH Chu, WH Chang, TC Hsu, SC Lin, CC Liu, AM Yang, ...World journal of gastroenterology: WJG 11 (27), 4215 47 2005
    • Hepatic Sarcomatoid Carcinoma in a Patient with Recurrent Cholelithiasis and Chronic Cholangitis: Report of a Case. AM Yang, MJ Chen, SC Shih, SC Lin, KM Chang, JC Lin Taiwan Journal of Gastroenterology 20 (4), 264-270 2003
    • Sonographic Evaluation of the Effect of Treating Hepatic Metastases from Gastrointestinal Stromal Tumor: A Case Report. AM Yang, SC Lin, TE Wang, SC Shih, MJ Huang Journal of Medical Ultrasound 11 (1), 7-12 2003

    Conference Paper

    • Intestinal Fungi Contribute to Development of Alcoholic Liver Disease. Hepatology 63 (1 SUPP), 24A-24A (Oral presentation in AASLD Liver Meeting 2016 in Boston).
    • Interleukin 10 Promoter Polymorphism Haplotypes and Tumor Necrosis Factor alpha Promoter Polymorphism are Associated with Alcoholic Liver Cirrhosis. Hepatol Int (2012) 6: 44 (Oral presentation in APASL Liver week 2012, Taipei)
    • Identification of serological biomarkers in alcoholic liver cirrhosis patients using Escherichia coli proteome chips. Hepatol Int (2013) 7(Suppl 1): 1. (Poster in APASL Liver week 2013, Singapore)
©2026行天宮醫療志業醫療財團法人恩主公醫院 En Chu Kong Hospital. All rights reserved. Web Design by FT
Top